What Factors Predict When Older Adults Will Stop Driving?
Eurasia Review
What factors lead older adults to stop driving? A new study followed older adults who had no memory or thinking problems to examine..
Cerebrospinal fluid
News and Video Search Results
News coverage
-
Global Latex Agglutination Test Kits Market Size To Worth USD 1083.41 Million By 2033 | CAGR of 5.53%
GlobeNewswire
-
Predicine to Present 9 Liquid Biopsy Studies at ASCO 2024
GlobeNewswire
-
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
GlobeNewswire
-
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
GlobeNewswire
- More about:
American Academy of Neurology
0 shares
1 views
You might like
Cerebrospinal fluid media coverage
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
GlobeNewswire
· Updated interim data from the upliFT-D trial in FTD-GRN demonstrated that Dose 1 PBFT02 achieved consistent elevation of CSF..
-
Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of Autoimmune Diseases of the Central Nervous System Published in Science Immunology
PR Newswire Asia
-
Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial
GlobeNewswire
-
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
GlobeNewswire
-
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
Advertisement
More coverage
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
GlobeNewswire
· *Significantly higher rate of improvement in ADAS-Cog 11 scores in each treatment dose relative to placebo for patients with..
-
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease
GlobeNewswire
-
Angle PLC Announces US and EU Patents for Innovative CellKeep(TM) Slide
Accesswire
-
Preliminary Results for the Year Ended 31 December 2023
GlobeNewswire
-
Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
GlobeNewswire